Thomas Stankovich
Known title: Chief Financial OfficerCIK: 0001181166
Thomas Stankovich's purchase track record
How the stock did after each of Thomas Stankovich's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since August 30, 2021
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-75.3%
3 months: -48.8%
Beat the S&P 500
0%
median -72.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/30/2023 | HIND | $27K | -77.2% | -83.1% | +7.2% |
| 5/31/2022 | HIND | $18K | -56.5% | -85.1% | -4.2% |
| 11/18/2021 | HIND | $40K | -36.0% | -59.1% | -17.1% |
| 8/30/2021 | HIND | $51K | -41.1% | -67.6% | -3.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HIND | ▼ Sell | Open Market | 48 | $12 | 5/31/2024 | View on chart |
| HIND | ▼ Sell | Open Market | 43 | $7 | 2/29/2024 | View on chart |
| HIND | ▼ Sell | Open Market | 42 | $11 | 12/31/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 39 | $9 | 11/30/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 131 | $35 | 10/25/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 39 | $36 | 10/11/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 118 | $105 | 9/1/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 39 | $55 | 8/24/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 108 | $154 | 8/4/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 106 | $156 | 7/6/2023 | View on chart |
| HIND | ▲ Buy | Open Market | 17,702 | $27K | 6/30/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 98 | $236 | 5/31/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 96 | $227 | 4/30/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 109 | $283 | 3/31/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 103 | $438 | 2/28/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 157 | $2K | 2/2/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 48 | $360 | 1/24/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 110 | $824 | 1/24/2023 | View on chart |
| HIND | ▼ Sell | Open Market | 5,144 | $778 | 12/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 2,213 | $334 | 12/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 364,756 | $62K | 11/28/2022 | View on chart |
| HIND | ▲ Buy | Grant | 364,756 | $0 | 11/17/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 5,883 | $2K | 11/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 2,510 | $684 | 11/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 5,809 | $2K | 10/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 2,484 | $699 | 10/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,828 | $2K | 9/6/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,728 | $2K | 8/5/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,630 | $3K | 7/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,478 | $4K | 6/1/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 200 | $178 | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 1,000 | $900 | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 7,995 | $7K | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 60 | $56 | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 6,539 | $6K | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 1,228 | $1K | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 78 | $68 | 5/31/2022 | View on chart |
| HIND | ▲ Buy | Open Market | 2,900 | $3K | 5/31/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,529 | $3K | 5/5/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 5,038 | $6K | 4/1/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 3,658 | $4K | 2/28/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 3,684 | $4K | 1/31/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 3,171 | $6K | 1/4/2022 | View on chart |
| HIND | ▼ Sell | Open Market | 4,304 | $8K | 12/2/2021 | View on chart |
| HIND | ▲ Buy | Open Market | 20,000 | $40K | 11/18/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 4,320 | $12K | 11/2/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 3,660 | $10K | 10/1/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 48,366 | $140K | 9/10/2021 | View on chart |
| HIND | ▲ Buy | Open Market | 15,000 | $51K | 8/30/2021 | View on chart |
| HIND | ▲ Buy | Open Market | 15,000 | $48K | 8/20/2021 | View on chart |
| HIND | ▲ Buy | Grant | 282,382 | $0 | 7/22/2021 | View on chart |
| HIND | ▲ Buy | Grant | 90,362 | $0 | 7/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vyome Holdings Gets USPTO Patent Allowance for VT-1908
Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.
Vyome Holdings Gets USPTO Patent Allowance for VT-1908. Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.